Lyrica (Pregabalin) Administered As An Add-On Therapy For Partial Seizures (LEADER) An Open-Label, Multicenter Add-On Therapy Trial.
Phase of Trial: Phase IV
Latest Information Update: 10 Dec 2018
At a glance
- Drugs Pregabalin (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Acronyms LEADER
- Sponsors Pfizer
- 14 Jul 2009 Actual patient number (98) added as reported by ClinicalTrials.gov.
- 22 Sep 2008 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 03 Jan 2008 Status changed from in progress to completed.